Solid Biosciences Inc (NASDAQ: SLDB) kicked off on Tuesday, up 9.16% from the previous trading day, before settling in for the closing price of $4.15. Over the past 52 weeks, SLDB has traded in a range of $2.41-$7.37.
A company in the Healthcare sector has jumped its sales by 41.25% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 31.21%. With a float of $58.35 million, this company’s outstanding shares have now reached $77.88 million.
In an organization with 100 employees, it is important to assess its efficiency.
Solid Biosciences Inc (SLDB) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Solid Biosciences Inc is 25.10%, while institutional ownership is 83.36%. The most recent insider transaction that took place on Oct 20 ’25, was worth 17,254. In this transaction Chief Medical Officer of this company sold 2,895 shares at a rate of $5.96, taking the stock ownership to the 33,819 shares. Before that another transaction happened on Mar 11 ’25, when Company’s Director bought 1,860 for $5.34, making the entire transaction worth $9,924. This insider now owns 2,960 shares in total.
Solid Biosciences Inc (SLDB) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -1 earnings per share (EPS), lower than consensus estimate (set at -0.78) by -0.22. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.51 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 31.21% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.41% during the next five years compared to 41.25% growth over the previous five years of trading.
Solid Biosciences Inc (NASDAQ: SLDB) Trading Performance Indicators
Take a look at Solid Biosciences Inc’s (SLDB) current performance indicators. Last quarter, stock had a quick ratio of 6.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.49, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -2.04 in one year’s time.
Technical Analysis of Solid Biosciences Inc (SLDB)
Let’s dig in a bit further. During the last 5-days, its volume was 1.33 million. That was inferior than the volume of 1.7 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 23.12%.
During the past 100 days, Solid Biosciences Inc’s (SLDB) raw stochastic average was set at 20.67%, which indicates a significant decrease from 32.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.41 in the past 14 days, which was higher than the 0.41 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.52, while its 200-day Moving Average is $4.80. However, in the short run, Solid Biosciences Inc’s stock first resistance to watch stands at $4.80. Second resistance stands at $5.08. The third major resistance level sits at $5.45. If the price goes on to break the first support level at $4.15, it is likely to go to the next support level at $3.78. Assuming the price breaks the second support level, the third support level stands at $3.50.
Solid Biosciences Inc (NASDAQ: SLDB) Key Stats
The company with the Market Capitalisation of 352.93 million has total of 77,910K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -124,700 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -45,780 K.
